BamSEC and AlphaSense Join Forces
Learn More

Kardigan Inc. – Material Contracts

NASDAQ: KARD    
Share price (7/9/26): $24.45    
Market cap (7/9/26): $2.144 billion

Material Contracts Filter

EX-10.3
from S-1/A 10 pages Kardigan, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 44 pages Kardigan, Inc. 2026 Stock Option and Incentive Plan
12/34/56
EX-10.18
from S-1 73 pages Lease and Lease Agreement Between Carnegie 506 Associates the Landlord and Kardigan Bio the Tenant for Leased Premises in 506 Carnegie Center Princeton, New Jersey February 18, 2025
12/34/56
EX-10.17
from S-1 126 pages The Cove Lease
12/34/56
EX-10.16
from S-1 93 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger by and Among Encarda, Inc., Rsf Merger Sub, Inc. Rancho Santa Fe Bio, Inc. and Shareholder Representative Services LLC, as the Representative Dated as of March 11, 2024
12/34/56
EX-10.15
from S-1 52 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger
12/34/56
EX-10.14
from S-1 39 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Mayo Foundation for Medical Education and Research Patent License and Know-How Agreement
12/34/56
EX-10.13
from S-1 53 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. License Agreement Between Sanofi and Rancho Santa Fe Bio, Inc. Dated as of June 2, 2021
12/34/56
EX-10.12
from S-1 56 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. License Agreement
12/34/56
EX-10.11
from S-1 65 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. License Agreement by and Between Encarda, Inc. and Bristol-Myers Squibb Company Dated as of November 4, 2024
12/34/56
EX-10.10
from S-1 64 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. License Agreement by and Between Encarda, Inc. and Myokardia, Inc. Dated as of November 4, 2024
12/34/56
EX-10.9
from S-1 15 pages Material contract
12/34/56
EX-10.8
from S-1 15 pages Material contract
12/34/56
EX-10.7
from S-1 17 pages Employment Agreement
12/34/56
EX-10.6
from S-1 3 pages Kardigan, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.5
from S-1 3 pages Kardigan, Inc. Senior Executive Cash Incentive Bonus Plan
12/34/56
EX-10.4
from S-1 34 pages Kardigan, Inc. Indemnification Agreement
12/34/56
EX-10.1
from S-1 91 pages Encarda, Inc. 2023 Stock Option and Grant Plan
12/34/56
EX-10.16
from DRS/A 93 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger by and Among Encarda, Inc., Rsf Merger Sub, Inc. Rancho Santa Fe Bio, Inc. and Shareholder Representative Services LLC, as the Representative Dated as of March 11, 2024
12/34/56
EX-10.15
from DRS/A 52 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger
12/34/56